ARCHIVES

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

Decade-Long Cover-up?

January 6, 1995

New Cooperative Group Funded

September 30, 1977

No Justification Provided: DePinho’s Nixing of Tenure Renewals May Bring Censure to MD Anderson

April 25, 2014

Letter to the Editor: Colleagues describe Bunn As Leader, Patient Advocate

January 12, 1996

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

NCI Grants Funding: New Funds Moved Into R01s, other Extramural Priorities

December 12, 1997